Alithea Casimir

Recommended Articles

• Gastroenteritis: The Treatment Options

  Treatments for gastroenteritis vary depending on the underlying cause. Normally, acute gastritis caused by non-steroidal anti-inflammatory medications and alcohol can be lessened by stopping the usage of such substances. On the other hand, chronic arthritis occurs due to an H. pylori infection,...

• The Many Uses of Coconut Oil for Your Health

  What is coconut oil?Coconut oil is also known as copra oil. It is a famous type of oil that is used primarily for cooking at many households, which is extracted from the meat of matured coconuts and is usually reaped from coconut palm trees.Coconut oil has several uses apart from being a type of...

• What Are the Causes and Symptoms of Parkinson's Disease?

  Parkinson’s disease is a progressive nervous disorder that affects an individual's movement and coordination. It is a degenerative disorder that affects the part of brain controlling movement and balance. The loss of muscle control is often seen in the form of tremors in the limbs, which is the...

• Celiac Disease and Type I Diabetes Patients at a Higher Risk for Fractures

  From time to time, patients may develop what is known as a comorbidity, which is essentially a word used to describe a situation wherein the subject is simultaneously diagnosed with two diseases or conditions.  This can occur for a multitude of reasons, one being that the first condition may very...

• Help for Anyone Newly Diagnosed with MS

  You have multiple sclerosis (MS). Now what? Whether you found out months ago or your doctor just told you days ago that you might or definitely do have MS, you are undoubtedly full of questions, confusion, and shock over the news. Regardless of where you are in the middle of full blown symptoms or...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...